Compare · MCK vs MEDS
MCK vs MEDS
Side-by-side comparison of McKesson Corporation (MCK) and TRxADE HEALTH Inc. (MEDS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MCK and MEDS operate in Other Pharmaceuticals (Health Care), so they compete in similar markets.
- MCK is the larger of the two at $99.94B, about 6591.2x MEDS ($15.2M).
- MCK has been more active in the news (3 items in the past 4 weeks vs 1 for MEDS).
- MCK has more recent analyst coverage (25 ratings vs 1 for MEDS).
- Company
- McKesson Corporation
- TRxADE HEALTH Inc.
- Price
- $829.10-0.28%
- $7.44+7.20%
- Market cap
- $99.94B
- $15.2M
- 1M return
- +10.34%
- -
- 1Y return
- +16.55%
- -
- Industry
- Other Pharmaceuticals
- Other Pharmaceuticals
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 3
- 1
- Recent ratings
- 25
- 1
McKesson Corporation
McKesson Corporation provides healthcare supply chain management, retail pharmacy, community oncology and specialty care, and healthcare information solutions in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment offers CoverMyMeds solution to help patients get the medications; RelayHealth, a workflow solution; RxCrossroads solution for therapies and interventions to biopharma manufacturers; and McKesson Prescription Automation, a customized pharmacy automation technology; and Multi-Client Central Fill as a Service, a pharmacy. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
TRxADE HEALTH Inc.
TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 members; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Land O' Lakes, Florida.
Latest MCK
- Chief Executive Officer Tyler Brian S. sold $6,715,898 worth of shares (8,463 units at $793.56) as part of a pre-agreed trading plan, decreasing direct ownership by 59% to 5,919 units (SEC Form 4)
- McKesson Corporation filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form DEFA14A filed by McKesson Corporation
- McKesson Corporation Announces First Quarter Fiscal 2027 Earnings Release Date
- Chief Executive Officer Tyler Brian S. sold $6,559,925 worth of shares (8,463 units at $775.13) as part of a pre-agreed trading plan, decreasing direct ownership by 37% to 14,382 units (SEC Form 4)
- SEC Form DEFA14A filed by McKesson Corporation
- SEC Form DEF 14A filed by McKesson Corporation
- McKesson Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Chief Executive Officer Tyler Brian S. sold $3,760,827 worth of shares (4,929 units at $763.00) as part of a pre-agreed trading plan, decreasing direct ownership by 18% to 22,845 units (SEC Form 4)
- SVP, Controller & CAO Rutledge Napoleon B Jr sold $101,612 worth of shares (133 units at $764.00) as part of a pre-agreed trading plan, decreasing direct ownership by 17% to 632 units (SEC Form 4)
Latest MEDS
- WELLGISTICS HEALTH, INC. OFFICIALLY CHANGES CORPORATE NAME TO DATAMEDS AI, INC.
- SCIENTURE to Present at The Small Cap Showcase & WTR Insights on June 9, 2026, in NYC
- Wellgistics Health Strengthens Executive Team and Board with Strategic Appointments to Accelerate Scale and Drive Shareholder Value
- Oragenics, Inc. Provides Shareholder Update on Strategic Progress and Announces Janet Huffman as Interim CEO
- TRxADE HEALTH Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits
- TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. and Ticker Symbol Change to "SCNX"
- TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc.
- SEC Form DEF 14C filed by TRxADE HEALTH Inc.
- SEC Form PRE 14C filed by TRxADE HEALTH Inc.
- SEC Form 10-Q filed by TRxADE HEALTH Inc.